Improved Differentiation of Pancreatic Tumors Using Contrast-Enhanced Endoscopic Ultrasound Christoph F. Dietrich, Andre Ignee, Barbara Braden, Ana Paula Barreiros, Michaela Ott, Michael Hocke Clinical Gastroenterology and Hepatology Volume 6, Issue 5, Pages 590-597.e1 (May 2008) DOI: 10.1016/j.cgh.2008.02.030 Copyright © 2008 AGA Institute Terms and Conditions
Figure 1 CE-EDUS in a patient with hypovascular ductal adenocarcinoma of the pancreas. (A) CDI and (B) contrast-enhanced Doppler ultrasound both revealed a hypovascular lesion. Clinical Gastroenterology and Hepatology 2008 6, 590-597.e1DOI: (10.1016/j.cgh.2008.02.030) Copyright © 2008 AGA Institute Terms and Conditions
Figure 2 CE-EDUS in a patient with a hypervascular neuroendocrine tumor. (A) CDI and (B) contrast-enhanced Doppler ultrasound both showed a hypervascular lesion. Clinical Gastroenterology and Hepatology 2008 6, 590-597.e1DOI: (10.1016/j.cgh.2008.02.030) Copyright © 2008 AGA Institute Terms and Conditions
Figure 3 CE-EDUS in a patient with a hypervascular serous microcystic adenoma of the pancreas. (A) CDI was not conclusive but (B–D) contrast-enhanced Doppler ultrasound revealed definite hypervascularity. In the initial arterial phase stimulated acoustic emission might be misleading. (E and F) Nonvascularized lesions also can be displayed using this method shown in a patient with thrombosed pseudoaneurysm. Note the avascular parts of thrombosis. Clinical Gastroenterology and Hepatology 2008 6, 590-597.e1DOI: (10.1016/j.cgh.2008.02.030) Copyright © 2008 AGA Institute Terms and Conditions